Graft-versus-Host Disease (GVHD)
specific14
Centers
2
Active Trials
$77M
Cancer Funding
Top Centers for Graft-versus-Host Disease (GVHD)(14)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 66.6 |
| 2 | Mount Sinai Tisch Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 64.1 |
| 3 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 61.6 |
| 4 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 59.1 |
| 5 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 57.9 |
| 6 | Penn State Cancer InstituteHershey, PA Active Research Program | 57.9 |
| 7 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 56.6 |
| 8 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program | 54.1 |
| 9 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 51.6 |
| 10 | Hollings Cancer CenterCharleston, SC NCI Clinical Active Research Program | 49.1 |
| 11 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 46.6 |
| 12 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 44.1 |
| 13 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 41.6 |
| 14 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program | 39.1 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →